SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ARIAD Pharmaceuticals
ARIA 23.990.0%Feb 17 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jim Haynes who wrote (697)9/20/1999 9:41:00 PM
From: LLCF  Read Replies (1) of 4474
 
<if the science is good, there are bigger companies which would pay a premium of the market cap to buy Ariad, >

The only thing we have to remember is that a buyer will be buying all outstanding shares, PLUS the shares that the convert holder is entitled to assuming conversion at what .85 now???? Anyone ever find out for sure if there are 5,000 or 10,000 of those bad boys out there??? Anyway your talking about at least 5mill more common the buyer would have to take out, right?

DAK
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News